Global Cyclic Peptides Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

November 2025 | 116 pages | ID: GB33658414A9EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Cyclic Peptides market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.

In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.

Customized cyclic peptides refer to cyclic peptides that are designed, synthesized, and optimized according to specific needs and application purposes, and different methods are used according to different functional requirements. Customized cyclization strategies include single/double/triple disulfide bonds, click cyclization, lactone, lactam, RCM, etc. The cyclization positions can include head-tail, head-side chain, side chain-side chain, and side chain-tail.

This report is a detailed and comprehensive analysis for global Cyclic Peptides market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Cyclic Peptides market size and forecasts, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2020-2031

Global Cyclic Peptides market size and forecasts by region and country, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2020-2031

Global Cyclic Peptides market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2020-2031

Global Cyclic Peptides market shares of main players, shipments in revenue ($ Million), sales quantity (kg), and ASP (US$/g), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cyclic Peptides
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace

This report profiles key players in the global Cyclic Peptides market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include JPT Peptide Technologies GmbH, BACHEM, CPC Scientific, Pepscan, United States Biological, RS Synthesis, Charnwood Discovery, Bio-Synthesis, WuXi STA, GL Biochem(Shanghai) Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Cyclic Peptides market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
  • Disulfide Bond Ring
  • Amide Ring
  • Other
Market segment by Application
  • Pharmaceuticals
  • Scientific Research
Major players covered
  • JPT Peptide Technologies GmbH
  • BACHEM
  • CPC Scientific
  • Pepscan
  • United States Biological
  • RS Synthesis
  • Charnwood Discovery
  • Bio-Synthesis
  • WuXi STA
  • GL Biochem(Shanghai) Ltd
  • Genscript
  • Motif Biotech
  • QYAOBIO
  • Novopro
  • Suzhou Motif Biotechnology
Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cyclic Peptides product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cyclic Peptides, with price, sales quantity, revenue, and global market share of Cyclic Peptides from 2020 to 2025.
Chapter 3, the Cyclic Peptides competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cyclic Peptides breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Cyclic Peptides market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cyclic Peptides.
Chapter 14 and 15, to describe Cyclic Peptides sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
  1.3.1 Overview: Global Cyclic Peptides Consumption Value by Type: 2020 Versus 2024 Versus 2031
  1.3.2 Disulfide Bond Ring
  1.3.3 Amide Ring
  1.3.4 Other
1.4 Market Analysis by Application
  1.4.1 Overview: Global Cyclic Peptides Consumption Value by Application: 2020 Versus 2024 Versus 2031
  1.4.2 Pharmaceuticals
  1.4.3 Scientific Research
1.5 Global Cyclic Peptides Market Size & Forecast
  1.5.1 Global Cyclic Peptides Consumption Value (2020 & 2024 & 2031)
  1.5.2 Global Cyclic Peptides Sales Quantity (2020-2031)
  1.5.3 Global Cyclic Peptides Average Price (2020-2031)

2 MANUFACTURERS PROFILES

2.1 JPT Peptide Technologies GmbH
  2.1.1 JPT Peptide Technologies GmbH Details
  2.1.2 JPT Peptide Technologies GmbH Major Business
  2.1.3 JPT Peptide Technologies GmbH Cyclic Peptides Product and Services
  2.1.4 JPT Peptide Technologies GmbH Cyclic Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  2.1.5 JPT Peptide Technologies GmbH Recent Developments/Updates
2.2 BACHEM
  2.2.1 BACHEM Details
  2.2.2 BACHEM Major Business
  2.2.3 BACHEM Cyclic Peptides Product and Services
  2.2.4 BACHEM Cyclic Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  2.2.5 BACHEM Recent Developments/Updates
2.3 CPC Scientific
  2.3.1 CPC Scientific Details
  2.3.2 CPC Scientific Major Business
  2.3.3 CPC Scientific Cyclic Peptides Product and Services
  2.3.4 CPC Scientific Cyclic Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  2.3.5 CPC Scientific Recent Developments/Updates
2.4 Pepscan
  2.4.1 Pepscan Details
  2.4.2 Pepscan Major Business
  2.4.3 Pepscan Cyclic Peptides Product and Services
  2.4.4 Pepscan Cyclic Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  2.4.5 Pepscan Recent Developments/Updates
2.5 United States Biological
  2.5.1 United States Biological Details
  2.5.2 United States Biological Major Business
  2.5.3 United States Biological Cyclic Peptides Product and Services
  2.5.4 United States Biological Cyclic Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  2.5.5 United States Biological Recent Developments/Updates
2.6 RS Synthesis
  2.6.1 RS Synthesis Details
  2.6.2 RS Synthesis Major Business
  2.6.3 RS Synthesis Cyclic Peptides Product and Services
  2.6.4 RS Synthesis Cyclic Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  2.6.5 RS Synthesis Recent Developments/Updates
2.7 Charnwood Discovery
  2.7.1 Charnwood Discovery Details
  2.7.2 Charnwood Discovery Major Business
  2.7.3 Charnwood Discovery Cyclic Peptides Product and Services
  2.7.4 Charnwood Discovery Cyclic Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  2.7.5 Charnwood Discovery Recent Developments/Updates
2.8 Bio-Synthesis
  2.8.1 Bio-Synthesis Details
  2.8.2 Bio-Synthesis Major Business
  2.8.3 Bio-Synthesis Cyclic Peptides Product and Services
  2.8.4 Bio-Synthesis Cyclic Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  2.8.5 Bio-Synthesis Recent Developments/Updates
2.9 WuXi STA
  2.9.1 WuXi STA Details
  2.9.2 WuXi STA Major Business
  2.9.3 WuXi STA Cyclic Peptides Product and Services
  2.9.4 WuXi STA Cyclic Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  2.9.5 WuXi STA Recent Developments/Updates
2.10 GL Biochem(Shanghai) Ltd
  2.10.1 GL Biochem(Shanghai) Ltd Details
  2.10.2 GL Biochem(Shanghai) Ltd Major Business
  2.10.3 GL Biochem(Shanghai) Ltd Cyclic Peptides Product and Services
  2.10.4 GL Biochem(Shanghai) Ltd Cyclic Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  2.10.5 GL Biochem(Shanghai) Ltd Recent Developments/Updates
2.11 Genscript
  2.11.1 Genscript Details
  2.11.2 Genscript Major Business
  2.11.3 Genscript Cyclic Peptides Product and Services
  2.11.4 Genscript Cyclic Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  2.11.5 Genscript Recent Developments/Updates
2.12 Motif Biotech
  2.12.1 Motif Biotech Details
  2.12.2 Motif Biotech Major Business
  2.12.3 Motif Biotech Cyclic Peptides Product and Services
  2.12.4 Motif Biotech Cyclic Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  2.12.5 Motif Biotech Recent Developments/Updates
2.13 QYAOBIO
  2.13.1 QYAOBIO Details
  2.13.2 QYAOBIO Major Business
  2.13.3 QYAOBIO Cyclic Peptides Product and Services
  2.13.4 QYAOBIO Cyclic Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  2.13.5 QYAOBIO Recent Developments/Updates
2.14 Novopro
  2.14.1 Novopro Details
  2.14.2 Novopro Major Business
  2.14.3 Novopro Cyclic Peptides Product and Services
  2.14.4 Novopro Cyclic Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  2.14.5 Novopro Recent Developments/Updates
2.15 Suzhou Motif Biotechnology
  2.15.1 Suzhou Motif Biotechnology Details
  2.15.2 Suzhou Motif Biotechnology Major Business
  2.15.3 Suzhou Motif Biotechnology Cyclic Peptides Product and Services
  2.15.4 Suzhou Motif Biotechnology Cyclic Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  2.15.5 Suzhou Motif Biotechnology Recent Developments/Updates

3 COMPETITIVE ENVIRONMENT: CYCLIC PEPTIDES BY MANUFACTURER

3.1 Global Cyclic Peptides Sales Quantity by Manufacturer (2020-2025)
3.2 Global Cyclic Peptides Revenue by Manufacturer (2020-2025)
3.3 Global Cyclic Peptides Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
  3.4.1 Producer Shipments of Cyclic Peptides by Manufacturer Revenue ($MM) and Market Share (%): 2024
  3.4.2 Top 3 Cyclic Peptides Manufacturer Market Share in 2024
  3.4.3 Top 6 Cyclic Peptides Manufacturer Market Share in 2024
3.5 Cyclic Peptides Market: Overall Company Footprint Analysis
  3.5.1 Cyclic Peptides Market: Region Footprint
  3.5.2 Cyclic Peptides Market: Company Product Type Footprint
  3.5.3 Cyclic Peptides Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 CONSUMPTION ANALYSIS BY REGION

4.1 Global Cyclic Peptides Market Size by Region
  4.1.1 Global Cyclic Peptides Sales Quantity by Region (2020-2031)
  4.1.2 Global Cyclic Peptides Consumption Value by Region (2020-2031)
  4.1.3 Global Cyclic Peptides Average Price by Region (2020-2031)
4.2 North America Cyclic Peptides Consumption Value (2020-2031)
4.3 Europe Cyclic Peptides Consumption Value (2020-2031)
4.4 Asia-Pacific Cyclic Peptides Consumption Value (2020-2031)
4.5 South America Cyclic Peptides Consumption Value (2020-2031)
4.6 Middle East & Africa Cyclic Peptides Consumption Value (2020-2031)

5 MARKET SEGMENT BY TYPE

5.1 Global Cyclic Peptides Sales Quantity by Type (2020-2031)
5.2 Global Cyclic Peptides Consumption Value by Type (2020-2031)
5.3 Global Cyclic Peptides Average Price by Type (2020-2031)

6 MARKET SEGMENT BY APPLICATION

6.1 Global Cyclic Peptides Sales Quantity by Application (2020-2031)
6.2 Global Cyclic Peptides Consumption Value by Application (2020-2031)
6.3 Global Cyclic Peptides Average Price by Application (2020-2031)

7 NORTH AMERICA

7.1 North America Cyclic Peptides Sales Quantity by Type (2020-2031)
7.2 North America Cyclic Peptides Sales Quantity by Application (2020-2031)
7.3 North America Cyclic Peptides Market Size by Country
  7.3.1 North America Cyclic Peptides Sales Quantity by Country (2020-2031)
  7.3.2 North America Cyclic Peptides Consumption Value by Country (2020-2031)
  7.3.3 United States Market Size and Forecast (2020-2031)
  7.3.4 Canada Market Size and Forecast (2020-2031)
  7.3.5 Mexico Market Size and Forecast (2020-2031)

8 EUROPE

8.1 Europe Cyclic Peptides Sales Quantity by Type (2020-2031)
8.2 Europe Cyclic Peptides Sales Quantity by Application (2020-2031)
8.3 Europe Cyclic Peptides Market Size by Country
  8.3.1 Europe Cyclic Peptides Sales Quantity by Country (2020-2031)
  8.3.2 Europe Cyclic Peptides Consumption Value by Country (2020-2031)
  8.3.3 Germany Market Size and Forecast (2020-2031)
  8.3.4 France Market Size and Forecast (2020-2031)
  8.3.5 United Kingdom Market Size and Forecast (2020-2031)
  8.3.6 Russia Market Size and Forecast (2020-2031)
  8.3.7 Italy Market Size and Forecast (2020-2031)

9 ASIA-PACIFIC

9.1 Asia-Pacific Cyclic Peptides Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Cyclic Peptides Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Cyclic Peptides Market Size by Region
  9.3.1 Asia-Pacific Cyclic Peptides Sales Quantity by Region (2020-2031)
  9.3.2 Asia-Pacific Cyclic Peptides Consumption Value by Region (2020-2031)
  9.3.3 China Market Size and Forecast (2020-2031)
  9.3.4 Japan Market Size and Forecast (2020-2031)
  9.3.5 South Korea Market Size and Forecast (2020-2031)
  9.3.6 India Market Size and Forecast (2020-2031)
  9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
  9.3.8 Australia Market Size and Forecast (2020-2031)

10 SOUTH AMERICA

10.1 South America Cyclic Peptides Sales Quantity by Type (2020-2031)
10.2 South America Cyclic Peptides Sales Quantity by Application (2020-2031)
10.3 South America Cyclic Peptides Market Size by Country
  10.3.1 South America Cyclic Peptides Sales Quantity by Country (2020-2031)
  10.3.2 South America Cyclic Peptides Consumption Value by Country (2020-2031)
  10.3.3 Brazil Market Size and Forecast (2020-2031)
  10.3.4 Argentina Market Size and Forecast (2020-2031)

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Cyclic Peptides Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Cyclic Peptides Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Cyclic Peptides Market Size by Country
  11.3.1 Middle East & Africa Cyclic Peptides Sales Quantity by Country (2020-2031)
  11.3.2 Middle East & Africa Cyclic Peptides Consumption Value by Country (2020-2031)
  11.3.3 Turkey Market Size and Forecast (2020-2031)
  11.3.4 Egypt Market Size and Forecast (2020-2031)
  11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
  11.3.6 South Africa Market Size and Forecast (2020-2031)

12 MARKET DYNAMICS

12.1 Cyclic Peptides Market Drivers
12.2 Cyclic Peptides Market Restraints
12.3 Cyclic Peptides Trends Analysis
12.4 Porters Five Forces Analysis
  12.4.1 Threat of New Entrants
  12.4.2 Bargaining Power of Suppliers
  12.4.3 Bargaining Power of Buyers
  12.4.4 Threat of Substitutes
  12.4.5 Competitive Rivalry

13 RAW MATERIAL AND INDUSTRY CHAIN

13.1 Raw Material of Cyclic Peptides and Key Manufacturers
13.2 Manufacturing Costs Percentage of Cyclic Peptides
13.3 Cyclic Peptides Production Process
13.4 Industry Value Chain Analysis

14 SHIPMENTS BY DISTRIBUTION CHANNEL

14.1 Sales Channel
  14.1.1 Direct to End-User
  14.1.2 Distributors
14.2 Cyclic Peptides Typical Distributors
14.3 Cyclic Peptides Typical Customers

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES

Table 1. Global Cyclic Peptides Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Cyclic Peptides Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. JPT Peptide Technologies GmbH Basic Information, Manufacturing Base and Competitors
Table 4. JPT Peptide Technologies GmbH Major Business
Table 5. JPT Peptide Technologies GmbH Cyclic Peptides Product and Services
Table 6. JPT Peptide Technologies GmbH Cyclic Peptides Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. JPT Peptide Technologies GmbH Recent Developments/Updates
Table 8. BACHEM Basic Information, Manufacturing Base and Competitors
Table 9. BACHEM Major Business
Table 10. BACHEM Cyclic Peptides Product and Services
Table 11. BACHEM Cyclic Peptides Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. BACHEM Recent Developments/Updates
Table 13. CPC Scientific Basic Information, Manufacturing Base and Competitors
Table 14. CPC Scientific Major Business
Table 15. CPC Scientific Cyclic Peptides Product and Services
Table 16. CPC Scientific Cyclic Peptides Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. CPC Scientific Recent Developments/Updates
Table 18. Pepscan Basic Information, Manufacturing Base and Competitors
Table 19. Pepscan Major Business
Table 20. Pepscan Cyclic Peptides Product and Services
Table 21. Pepscan Cyclic Peptides Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Pepscan Recent Developments/Updates
Table 23. United States Biological Basic Information, Manufacturing Base and Competitors
Table 24. United States Biological Major Business
Table 25. United States Biological Cyclic Peptides Product and Services
Table 26. United States Biological Cyclic Peptides Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. United States Biological Recent Developments/Updates
Table 28. RS Synthesis Basic Information, Manufacturing Base and Competitors
Table 29. RS Synthesis Major Business
Table 30. RS Synthesis Cyclic Peptides Product and Services
Table 31. RS Synthesis Cyclic Peptides Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. RS Synthesis Recent Developments/Updates
Table 33. Charnwood Discovery Basic Information, Manufacturing Base and Competitors
Table 34. Charnwood Discovery Major Business
Table 35. Charnwood Discovery Cyclic Peptides Product and Services
Table 36. Charnwood Discovery Cyclic Peptides Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Charnwood Discovery Recent Developments/Updates
Table 38. Bio-Synthesis Basic Information, Manufacturing Base and Competitors
Table 39. Bio-Synthesis Major Business
Table 40. Bio-Synthesis Cyclic Peptides Product and Services
Table 41. Bio-Synthesis Cyclic Peptides Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Bio-Synthesis Recent Developments/Updates
Table 43. WuXi STA Basic Information, Manufacturing Base and Competitors
Table 44. WuXi STA Major Business
Table 45. WuXi STA Cyclic Peptides Product and Services
Table 46. WuXi STA Cyclic Peptides Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. WuXi STA Recent Developments/Updates
Table 48. GL Biochem(Shanghai) Ltd Basic Information, Manufacturing Base and Competitors
Table 49. GL Biochem(Shanghai) Ltd Major Business
Table 50. GL Biochem(Shanghai) Ltd Cyclic Peptides Product and Services
Table 51. GL Biochem(Shanghai) Ltd Cyclic Peptides Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. GL Biochem(Shanghai) Ltd Recent Developments/Updates
Table 53. Genscript Basic Information, Manufacturing Base and Competitors
Table 54. Genscript Major Business
Table 55. Genscript Cyclic Peptides Product and Services
Table 56. Genscript Cyclic Peptides Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Genscript Recent Developments/Updates
Table 58. Motif Biotech Basic Information, Manufacturing Base and Competitors
Table 59. Motif Biotech Major Business
Table 60. Motif Biotech Cyclic Peptides Product and Services
Table 61. Motif Biotech Cyclic Peptides Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Motif Biotech Recent Developments/Updates
Table 63. QYAOBIO Basic Information, Manufacturing Base and Competitors
Table 64. QYAOBIO Major Business
Table 65. QYAOBIO Cyclic Peptides Product and Services
Table 66. QYAOBIO Cyclic Peptides Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 67. QYAOBIO Recent Developments/Updates
Table 68. Novopro Basic Information, Manufacturing Base and Competitors
Table 69. Novopro Major Business
Table 70. Novopro Cyclic Peptides Product and Services
Table 71. Novopro Cyclic Peptides Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 72. Novopro Recent Developments/Updates
Table 73. Suzhou Motif Biotechnology Basic Information, Manufacturing Base and Competitors
Table 74. Suzhou Motif Biotechnology Major Business
Table 75. Suzhou Motif Biotechnology Cyclic Peptides Product and Services
Table 76. Suzhou Motif Biotechnology Cyclic Peptides Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 77. Suzhou Motif Biotechnology Recent Developments/Updates
Table 78. Global Cyclic Peptides Sales Quantity by Manufacturer (2020-2025) & (kg)
Table 79. Global Cyclic Peptides Revenue by Manufacturer (2020-2025) & (USD Million)
Table 80. Global Cyclic Peptides Average Price by Manufacturer (2020-2025) & (US$/g)
Table 81. Market Position of Manufacturers in Cyclic Peptides, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 82. Head Office and Cyclic Peptides Production Site of Key Manufacturer
Table 83. Cyclic Peptides Market: Company Product Type Footprint
Table 84. Cyclic Peptides Market: Company Product Application Footprint
Table 85. Cyclic Peptides New Market Entrants and Barriers to Market Entry
Table 86. Cyclic Peptides Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Cyclic Peptides Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 88. Global Cyclic Peptides Sales Quantity by Region (2020-2025) & (kg)
Table 89. Global Cyclic Peptides Sales Quantity by Region (2026-2031) & (kg)
Table 90. Global Cyclic Peptides Consumption Value by Region (2020-2025) & (USD Million)
Table 91. Global Cyclic Peptides Consumption Value by Region (2026-2031) & (USD Million)
Table 92. Global Cyclic Peptides Average Price by Region (2020-2025) & (US$/g)
Table 93. Global Cyclic Peptides Average Price by Region (2026-2031) & (US$/g)
Table 94. Global Cyclic Peptides Sales Quantity by Type (2020-2025) & (kg)
Table 95. Global Cyclic Peptides Sales Quantity by Type (2026-2031) & (kg)
Table 96. Global Cyclic Peptides Consumption Value by Type (2020-2025) & (USD Million)
Table 97. Global Cyclic Peptides Consumption Value by Type (2026-2031) & (USD Million)
Table 98. Global Cyclic Peptides Average Price by Type (2020-2025) & (US$/g)
Table 99. Global Cyclic Peptides Average Price by Type (2026-2031) & (US$/g)
Table 100. Global Cyclic Peptides Sales Quantity by Application (2020-2025) & (kg)
Table 101. Global Cyclic Peptides Sales Quantity by Application (2026-2031) & (kg)
Table 102. Global Cyclic Peptides Consumption Value by Application (2020-2025) & (USD Million)
Table 103. Global Cyclic Peptides Consumption Value by Application (2026-2031) & (USD Million)
Table 104. Global Cyclic Peptides Average Price by Application (2020-2025) & (US$/g)
Table 105. Global Cyclic Peptides Average Price by Application (2026-2031) & (US$/g)
Table 106. North America Cyclic Peptides Sales Quantity by Type (2020-2025) & (kg)
Table 107. North America Cyclic Peptides Sales Quantity by Type (2026-2031) & (kg)
Table 108. North America Cyclic Peptides Sales Quantity by Application (2020-2025) & (kg)
Table 109. North America Cyclic Peptides Sales Quantity by Application (2026-2031) & (kg)
Table 110. North America Cyclic Peptides Sales Quantity by Country (2020-2025) & (kg)
Table 111. North America Cyclic Peptides Sales Quantity by Country (2026-2031) & (kg)
Table 112. North America Cyclic Peptides Consumption Value by Country (2020-2025) & (USD Million)
Table 113. North America Cyclic Peptides Consumption Value by Country (2026-2031) & (USD Million)
Table 114. Europe Cyclic Peptides Sales Quantity by Type (2020-2025) & (kg)
Table 115. Europe Cyclic Peptides Sales Quantity by Type (2026-2031) & (kg)
Table 116. Europe Cyclic Peptides Sales Quantity by Application (2020-2025) & (kg)
Table 117. Europe Cyclic Peptides Sales Quantity by Application (2026-2031) & (kg)
Table 118. Europe Cyclic Peptides Sales Quantity by Country (2020-2025) & (kg)
Table 119. Europe Cyclic Peptides Sales Quantity by Country (2026-2031) & (kg)
Table 120. Europe Cyclic Peptides Consumption Value by Country (2020-2025) & (USD Million)
Table 121. Europe Cyclic Peptides Consumption Value by Country (2026-2031) & (USD Million)
Table 122. Asia-Pacific Cyclic Peptides Sales Quantity by Type (2020-2025) & (kg)
Table 123. Asia-Pacific Cyclic Peptides Sales Quantity by Type (2026-2031) & (kg)
Table 124. Asia-Pacific Cyclic Peptides Sales Quantity by Application (2020-2025) & (kg)
Table 125. Asia-Pacific Cyclic Peptides Sales Quantity by Application (2026-2031) & (kg)
Table 126. Asia-Pacific Cyclic Peptides Sales Quantity by Region (2020-2025) & (kg)
Table 127. Asia-Pacific Cyclic Peptides Sales Quantity by Region (2026-2031) & (kg)
Table 128. Asia-Pacific Cyclic Peptides Consumption Value by Region (2020-2025) & (USD Million)
Table 129. Asia-Pacific Cyclic Peptides Consumption Value by Region (2026-2031) & (USD Million)
Table 130. South America Cyclic Peptides Sales Quantity by Type (2020-2025) & (kg)
Table 131. South America Cyclic Peptides Sales Quantity by Type (2026-2031) & (kg)
Table 132. South America Cyclic Peptides Sales Quantity by Application (2020-2025) & (kg)
Table 133. South America Cyclic Peptides Sales Quantity by Application (2026-2031) & (kg)
Table 134. South America Cyclic Peptides Sales Quantity by Country (2020-2025) & (kg)
Table 135. South America Cyclic Peptides Sales Quantity by Country (2026-2031) & (kg)
Table 136. South America Cyclic Peptides Consumption Value by Country (2020-2025) & (USD Million)
Table 137. South America Cyclic Peptides Consumption Value by Country (2026-2031) & (USD Million)
Table 138. Middle East & Africa Cyclic Peptides Sales Quantity by Type (2020-2025) & (kg)
Table 139. Middle East & Africa Cyclic Peptides Sales Quantity by Type (2026-2031) & (kg)
Table 140. Middle East & Africa Cyclic Peptides Sales Quantity by Application (2020-2025) & (kg)
Table 141. Middle East & Africa Cyclic Peptides Sales Quantity by Application (2026-2031) & (kg)
Table 142. Middle East & Africa Cyclic Peptides Sales Quantity by Country (2020-2025) & (kg)
Table 143. Middle East & Africa Cyclic Peptides Sales Quantity by Country (2026-2031) & (kg)
Table 144. Middle East & Africa Cyclic Peptides Consumption Value by Country (2020-2025) & (USD Million)
Table 145. Middle East & Africa Cyclic Peptides Consumption Value by Country (2026-2031) & (USD Million)
Table 146. Cyclic Peptides Raw Material
Table 147. Key Manufacturers of Cyclic Peptides Raw Materials
Table 148. Cyclic Peptides Typical Distributors
Table 149. Cyclic Peptides Typical Customers

LIST OF FIGURES

Figure 1. Cyclic Peptides Picture
Figure 2. Global Cyclic Peptides Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Cyclic Peptides Revenue Market Share by Type in 2024
Figure 4. Disulfide Bond Ring Examples
Figure 5. Amide Ring Examples
Figure 6. Other Examples
Figure 7. Global Cyclic Peptides Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 8. Global Cyclic Peptides Revenue Market Share by Application in 2024
Figure 9. Pharmaceuticals Examples
Figure 10. Scientific Research Examples
Figure 11. Global Cyclic Peptides Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 12. Global Cyclic Peptides Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 13. Global Cyclic Peptides Sales Quantity (2020-2031) & (kg)
Figure 14. Global Cyclic Peptides Price (2020-2031) & (US$/g)
Figure 15. Global Cyclic Peptides Sales Quantity Market Share by Manufacturer in 2024
Figure 16. Global Cyclic Peptides Revenue Market Share by Manufacturer in 2024
Figure 17. Producer Shipments of Cyclic Peptides by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 18. Top 3 Cyclic Peptides Manufacturer (Revenue) Market Share in 2024
Figure 19. Top 6 Cyclic Peptides Manufacturer (Revenue) Market Share in 2024
Figure 20. Global Cyclic Peptides Sales Quantity Market Share by Region (2020-2031)
Figure 21. Global Cyclic Peptides Consumption Value Market Share by Region (2020-2031)
Figure 22. North America Cyclic Peptides Consumption Value (2020-2031) & (USD Million)
Figure 23. Europe Cyclic Peptides Consumption Value (2020-2031) & (USD Million)
Figure 24. Asia-Pacific Cyclic Peptides Consumption Value (2020-2031) & (USD Million)
Figure 25. South America Cyclic Peptides Consumption Value (2020-2031) & (USD Million)
Figure 26. Middle East & Africa Cyclic Peptides Consumption Value (2020-2031) & (USD Million)
Figure 27. Global Cyclic Peptides Sales Quantity Market Share by Type (2020-2031)
Figure 28. Global Cyclic Peptides Consumption Value Market Share by Type (2020-2031)
Figure 29. Global Cyclic Peptides Average Price by Type (2020-2031) & (US$/g)
Figure 30. Global Cyclic Peptides Sales Quantity Market Share by Application (2020-2031)
Figure 31. Global Cyclic Peptides Revenue Market Share by Application (2020-2031)
Figure 32. Global Cyclic Peptides Average Price by Application (2020-2031) & (US$/g)
Figure 33. North America Cyclic Peptides Sales Quantity Market Share by Type (2020-2031)
Figure 34. North America Cyclic Peptides Sales Quantity Market Share by Application (2020-2031)
Figure 35. North America Cyclic Peptides Sales Quantity Market Share by Country (2020-2031)
Figure 36. North America Cyclic Peptides Consumption Value Market Share by Country (2020-2031)
Figure 37. United States Cyclic Peptides Consumption Value (2020-2031) & (USD Million)
Figure 38. Canada Cyclic Peptides Consumption Value (2020-2031) & (USD Million)
Figure 39. Mexico Cyclic Peptides Consumption Value (2020-2031) & (USD Million)
Figure 40. Europe Cyclic Peptides Sales Quantity Market Share by Type (2020-2031)
Figure 41. Europe Cyclic Peptides Sales Quantity Market Share by Application (2020-2031)
Figure 42. Europe Cyclic Peptides Sales Quantity Market Share by Country (2020-2031)
Figure 43. Europe Cyclic Peptides Consumption Value Market Share by Country (2020-2031)
Figure 44. Germany Cyclic Peptides Consumption Value (2020-2031) & (USD Million)
Figure 45. France Cyclic Peptides Consumption Value (2020-2031) & (USD Million)
Figure 46. United Kingdom Cyclic Peptides Consumption Value (2020-2031) & (USD Million)
Figure 47. Russia Cyclic Peptides Consumption Value (2020-2031) & (USD Million)
Figure 48. Italy Cyclic Peptides Consumption Value (2020-2031) & (USD Million)
Figure 49. Asia-Pacific Cyclic Peptides Sales Quantity Market Share by Type (2020-2031)
Figure 50. Asia-Pacific Cyclic Peptides Sales Quantity Market Share by Application (2020-2031)
Figure 51. Asia-Pacific Cyclic Peptides Sales Quantity Market Share by Region (2020-2031)
Figure 52. Asia-Pacific Cyclic Peptides Consumption Value Market Share by Region (2020-2031)
Figure 53. China Cyclic Peptides Consumption Value (2020-2031) & (USD Million)
Figure 54. Japan Cyclic Peptides Consumption Value (2020-2031) & (USD Million)
Figure 55. South Korea Cyclic Peptides Consumption Value (2020-2031) & (USD Million)
Figure 56. India Cyclic Peptides Consumption Value (2020-2031) & (USD Million)
Figure 57. Southeast Asia Cyclic Peptides Consumption Value (2020-2031) & (USD Million)
Figure 58. Australia Cyclic Peptides Consumption Value (2020-2031) & (USD Million)
Figure 59. South America Cyclic Peptides Sales Quantity Market Share by Type (2020-2031)
Figure 60. South America Cyclic Peptides Sales Quantity Market Share by Application (2020-2031)
Figure 61. South America Cyclic Peptides Sales Quantity Market Share by Country (2020-2031)
Figure 62. South America Cyclic Peptides Consumption Value Market Share by Country (2020-2031)
Figure 63. Brazil Cyclic Peptides Consumption Value (2020-2031) & (USD Million)
Figure 64. Argentina Cyclic Peptides Consumption Value (2020-2031) & (USD Million)
Figure 65. Middle East & Africa Cyclic Peptides Sales Quantity Market Share by Type (2020-2031)
Figure 66. Middle East & Africa Cyclic Peptides Sales Quantity Market Share by Application (2020-2031)
Figure 67. Middle East & Africa Cyclic Peptides Sales Quantity Market Share by Country (2020-2031)
Figure 68. Middle East & Africa Cyclic Peptides Consumption Value Market Share by Country (2020-2031)
Figure 69. Turkey Cyclic Peptides Consumption Value (2020-2031) & (USD Million)
Figure 70. Egypt Cyclic Peptides Consumption Value (2020-2031) & (USD Million)
Figure 71. Saudi Arabia Cyclic Peptides Consumption Value (2020-2031) & (USD Million)
Figure 72. South Africa Cyclic Peptides Consumption Value (2020-2031) & (USD Million)
Figure 73. Cyclic Peptides Market Drivers
Figure 74. Cyclic Peptides Market Restraints
Figure 75. Cyclic Peptides Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Cyclic Peptides in 2024
Figure 78. Manufacturing Process Analysis of Cyclic Peptides
Figure 79. Cyclic Peptides Industrial Chain
Figure 80. Sales Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source


More Publications